100700 — Sewoon Medical Co Balance Sheet
0.000.00%
- KR₩106bn
- KR₩10bn
- KR₩64bn
Annual balance sheet for Sewoon Medical Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | Annual Audited Accounts | ARS | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 51,852 | 57,003 | 75,710 | 86,098 | 97,024 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 12,118 | 13,396 | 12,922 | 12,777 | 13,241 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 82,819 | 91,588 | 107,929 | 119,381 | 129,155 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 38,184 | 37,884 | 35,571 | 34,328 | 31,937 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 124,725 | 132,479 | 146,612 | 156,848 | 163,872 |
| Accounts Payable | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 8,160 | 6,697 | 8,297 | 7,010 | 8,858 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Minority Interest | |||||
| Total Liabilities | 10,590 | 9,474 | 11,455 | 10,730 | 12,700 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Other Equity | |||||
| Total Equity | 114,135 | 123,005 | 135,157 | 146,118 | 151,172 |
| Total Liabilities & Shareholders' Equity | 124,725 | 132,479 | 146,612 | 156,848 | 163,872 |
| Total Common Shares Outstanding |